Kang Lin

发表

Enhancement of Human Immunodeficiency Virus Type 1 lnCection by Antisera to Peptides from the Envelope Glycoproteins gp120/gp41

Shibo Jiang, A. Neurath, Kang Lin, 2003 .

HIV-1 inhibition by a peptide

Shibo Jiang, Shibo Jiang, A. Neurath, 1993, Nature.

3-Hydroxyphthaloyl-β-Lactoglobulin. I. Optimization of Production and Comparison with other Compounds Considered for Chemoprophylaxis of Mucosally Transmitted Human Immunodeficiency Virus Type 1

A. Debnath, Shibo Jiang, A. Neurath, 1997 .

3-Hydroxyphthaloyl-β-Lactoglobulin. II. Anti-Human Immunodeficiency Virus Type 1 Activity in in Vitro Environments Relevant to Prevention of Sexual Transmission of the Virus

A. Debnath, Shibo Jiang, A. Neurath, 1997 .

A Conformation-Specific Monoclonal Antibody Reacting with Fusion-Active gp41 from the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein

Min Lu, Shibo Jiang, Kang Lin, 1998, Journal of Virology.

Tin Protoporphyrin IX Used in Control of Heme Metabolism in Humans Effectively Inhibits HIV-1 Infection

A. Debnath, Shibo Jiang, A. Neurath, 1994 .

Studies on the action of 2,3-epoxysqualene-sterol cyclase on unnatural substrates produced by alkylidene transfer from sulfonium alkylides to 4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenal

E. Corey, Kang Lin, M. Jautelat, 1968 .

Bovine β–lactoglobulin modified by 3–hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV

Shibo Jiang, A. Debnath, Shibo Jiang, 1996, Nature Medicine.

A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.

A. Debnath, S. Jiang, K. Lin, 1999, Journal of virological methods.

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 [published erratum appears in J Exp Med 1992 Feb 1;175(2):621]

Shibo Jiang, A. Neurath, Kang Lin, 1991, The Journal of experimental medicine.

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

A. Debnath, S. Jiang, A. Neurath, 1994, Journal of medicinal chemistry.

Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.

S. Jiang, A. Neurath, N. Strick, 1993, Biochemical and biophysical research communications.

Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.

S. Jiang, A. Neurath, N. Strick, 1995, AIDS research and human retroviruses.